Ameliorating Contrast Induced Nephropathy After Coronary Angiography
Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
Given the limited understanding of the impact of statin and N-acetyl cysteine use before
angiography in preventing contrast-induced nephropathy (CIN), the objective of this study is
to evaluate the effectiveness of atorvastatin in preventing CIN among patients undergoing
coronary angiography.